FDG positron emission tomography for evaluating esophageal cancer.

FDG positron emission tomography for evaluating esophageal cancer. [electronic resource] - Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel Dec 2001 - 13-6 p. digital

Publication Type: Comparative Study; Journal Article


Blue Cross Blue Shield Insurance Plans
Esophageal Neoplasms--diagnostic imaging
Humans
Insurance Coverage
Neoplasm Staging--instrumentation
Sensitivity and Specificity
Technology Assessment, Biomedical
Tomography, Emission-Computed--instrumentation
Tomography, X-Ray Computed
Treatment Outcome
United States
United States Food and Drug Administration